疫苗注射相关肩部损伤(SIRVA):2010-2016年向国家疫苗伤害补偿计划提出的索赔申请
该研究对美国国家疫苗伤害补偿计划(VICP)数据库中2010-2016年建议予以补偿的SIRVA索赔申请进行描述性分析,共识别476例,索赔数从2011年2例增至2016年227例,84.0%涉及流感疫苗,82.8%为女性,36.1%报告手臂注射位置过高。作者认为注射位置过高可能因误入非肌肉组织而成为风险因素,并建议医护人员注意正确注射技术与解剖标志。
要点
- 2010-2016年VICP建议补偿的SIRVA索赔共476例,从2011年2例增至2016年227例。
- 84.0%的病例涉及流感疫苗,82.8%为女性,中位年龄51岁,中位BMI 25.1(范围17.0-48.9)。
- 36.1%报告手臂注射位置过高,作者认为注射位置过高可能因误入非肌肉组织而成为风险因素。
核心结论
- 大多数被建议补偿的SIRVA索赔为女性且涉及流感疫苗。
- 手臂注射位置过高可能因误入 underlying 非肌肉组织而成为风险因素。
- 医护人员在接种疫苗时应了解正确的注射技术和解剖标志。
研究设计与样本
- 对VICP伤害补偿系统数据库中的SIRVA及类SIRVA损伤医学报告进行查询,医学报告包括索赔申请摘要、支持文件及VICP临床审查者的诊断和补偿标准评估。
- 对VICP建议按SIRVA损伤予以补偿的索赔申请进行描述性分析,共识别476例建议补偿的索赔。
主要发现
- 每年索赔数从2011年(分析期第一个完整年)的2例增至2016年的227例。
- 中位年龄51岁,82.8%为女性,中位BMI 25.1(范围17.0-48.9)。
- 400例(84.0%)涉及流感疫苗。
- 接种地点最常见为药房或商店(n=168;35.3%),其次为医生办公室(n=147;30.9%)。
- 不到一半的病例报告了疑似接种错误;172例(36.1%)报告手臂「注射位置过高」。
临床怎么用
- 医护人员在接种疫苗时应了解正确的注射技术和解剖标志。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2010, petitioner claims of shoulder injury related to vaccine administration (SIRVA) to the National Vaccine Injury Compensation Program (VICP) have been increasing. OBJECTIVE: To conduct a scientific review of clinical characteristics of SIRVA petitions to the VICP. METHODS: We queried the VICP's Injury Compensation System database for medical reports of alleged SIRVA and SIRVA-like injuries. Medical reports are summaries of petitioner claims and supporting documentation along with a VICP clinician reviewer diagnosis and assessment of criteria for concession. We conducted a descriptive analysis of SIRVA petitioner claims recommended by the VICP for concession as SIRVA injuries. RESULTS: We identified 476 petitioner claims recommended for concession. Claims per year increased from two in 2011, the first full year in the analytic period, to 227 in 2016. Median age was 51 years, 82.8% were women, and median body mass index was 25.1 (range 17.0-48.9). Four hundred cases (84.0%) involved influenza vaccine. Pharmacy or store (n = 168; 35.3%) was the most common place of vaccination followed by doctor's office (n = 147; 30.9%). Fewer than half of cases reported a suspected administration error; 172 (36.1%) reported 'injection too high' on the arm. Shoulder pain, rotator cuff problems, and bursitis were common initial diagnoses. Most (80.0%) cases received physical or occupational therapy, 60.1% had at least one steroid injection, and 32.6% had surgery. Most (71.9%) healthcare providers who gave opinions on causality considered the injury was caused by vaccination. A minority (24.3%) of cases indicated that symptoms had resolved by the last visit available in medical records. CONCLUSIONS: Most conceded claims for SIRVA were in women and involved influenza vaccines. Injection too high on the arm could be a factor due to the risk of injecting into underlying non-muscular tissues. Healthcare providers should be aware of proper injection technique and anatomical landmarks when administering vaccines.
引用
- Hesse EM, Atanasoff S, Hibbs BF, et al. Shoulder Injury Related to Vaccine Administration (SIRVA): Petitioner claims to the National Vaccine Injury Compensation Program, 2010-2016. Vaccine. 2019. PMID: 31771864. doi:10.1016/j.vaccine.2019.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。